Lawrence Russell Smith, VP, Vaccine Research at VICAL INC (VICL), sold 12,500 shares at $1.25 ($16K) on 2014-08-26, disclosed to the SEC on 2014-08-27.
Scheduled sale ($16k) by VP, Vaccine Research under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VICL | SELL | 2017-01-13 | $134 | — | Filing → |
| VICL | SELL | 2016-10-12 | $165 | — | Filing → |
| VICL | SELL | 2016-07-13 | $241 | — | Filing → |